OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
JOURNAL OF RHEUMATOLOGY, cilt.44, sa.10, ss.1529-1535, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 44 Sayı: 10
- Basım Tarihi: 2017
- Doi Numarası: 10.3899/jrheum.161139
- Dergi Adı: JOURNAL OF RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1529-1535
- Anahtar Kelimeler: ANCA-ASSOCIATED VASCULITIS, PATIENT-REPORTED OUTCOMES, PROMIS, ICF, OMERACT, QUALITY-OF-LIFE, ANCA-ASSOCIATED VASCULITIS, WEGENERS-GRANULOMATOSIS, CLINICAL-TRIALS, CORE SET, INVOLVEMENT
- Marmara Üniversitesi Adresli: Evet
Özet
Objective. The antineutrophil cytoplasmic antibody-associated vasculitides (AAV) are multiorgan diseases. Patients with AAV report impairment in their health-related quality of life (HRQOL) and have different priorities regarding disease assessment compared with physicians. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group previously received endorsement for a core set of domains in AAV. Two approaches to measure patient-reported outcomes (PRO) were presented at OMERACT 2016.